Literature DB >> 22965324

Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality.

Thomas W K Battey1, Guido J Falcone, Alison M Ayres, Kristin Schwab, Anand Viswanathan, Kristen A McNamara, Zora Y DiPucchio, Steven M Greenberg, Kevin N Sheth, Joshua N Goldstein, Jonathan Rosand.   

Abstract

INTRODUCTION: Intracerebral hemorrhage (ICH) is a highly fatal disease with few proven treatments. Data to guide clinician decisions for therapies, including antiepileptic drugs (AED), are limited. Published studies on AED treatment in ICH have provided conflicting results. We investigated the effect of AED treatment on 90-day mortality after ICH in a large prospectively ascertained cohort.
METHODS: We conducted a retrospective analysis of a prospectively assembled cohort of patients with ICH in the supratentorial regions, comparing 90-day mortality and modified Rankin Score among 543 patients treated with AED during hospitalization and 639 AED-free ICH. Supratentorial ICH location was categorized as lobar or deep hemispheric.
RESULTS: Multivariate analysis demonstrated an association between AED treatment and reduced 90-day mortality in supratentorial ICH (OR = 0.62, 95 % CI 0.42-0.90, p = 0.01) and the subset of lobar ICH (OR = 0.49, 95 % CI 0.25-0.96, p = 0.04). When analyses were restricted to subjects surviving longer than 5 days from ICH, however, no association between AED treatment and a 90-day outcome, regardless of hemorrhage location (all p > 0.15), was detected, despite more than adequate power to detect the originally observed association.
CONCLUSION: These results suggest that AED treatment in acute ICH is not associated with 90-day mortality or outcome and that any detected association could arise by confounding by indication, in which the most severely affected patients are those in whom AEDs are prescribed. They provide a cautionary example of the limitations of drawing conclusions about treatment effects from observational data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965324      PMCID: PMC3707622          DOI: 10.1007/s12028-012-9776-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  12 in total

Review 1.  Spontaneous intracerebral hemorrhage.

Authors:  A I Qureshi; S Tuhrim; J P Broderick; H H Batjer; H Hondo; D F Hanley
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

2.  Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.

Authors:  Scott Taylor; Robin J Heinrichs; Jeff M Janzen; As'ad Ehtisham
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy.

Authors:  Jun Morioka; Masami Fujii; Shoichi Kato; Hirosuke Fujisawa; Tatsuo Akimura; Michiyasu Suzuki; Shotai Kobayashi
Journal:  Surg Neurol       Date:  2006-01

4.  Confounding control in healthcare database research: challenges and potential approaches.

Authors:  M Alan Brookhart; Til Stürmer; Robert J Glynn; Jeremy Rassen; Sebastian Schneeweiss
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

5.  The prophylactic use of an antiepileptic drug in intracerebral hemorrhage.

Authors:  Robert T Reddig; Kathryn E Nixdorf; Matthew B Jensen
Journal:  Clin Neurol Neurosurg       Date:  2011-08-06       Impact factor: 1.876

6.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.

Authors:  J J Flibotte; N Hagan; J O'Donnell; S M Greenberg; J Rosand
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

7.  Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome.

Authors:  P M Vespa; K O'Phelan; M Shah; J Mirabelli; S Starkman; C Kidwell; J Saver; M R Nuwer; J G Frazee; D A McArthur; N A Martin
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

8.  Prophylactic antiepileptic drug use is associated with poor outcome following ICH.

Authors:  Steven R Messé; Lauren H Sansing; Brett L Cucchiara; Susan T Herman; Patrick D Lyden; Scott E Kasner
Journal:  Neurocrit Care       Date:  2009-03-25       Impact factor: 3.210

9.  Anticonvulsant use and outcomes after intracerebral hemorrhage.

Authors:  Andrew M Naidech; Rajeev K Garg; Storm Liebling; Kimberly Levasseur; Micheal P Macken; Stephan U Schuele; H Hunt Batjer
Journal:  Stroke       Date:  2009-09-24       Impact factor: 7.914

10.  Effect of statins on intracerebral hemorrhage outcome and recurrence.

Authors:  Emilie FitzMaurice; Lauren Wendell; Ryan Snider; Kristin Schwab; Rishi Chanderraj; Cathrine Kinnecom; Kaveer Nandigam; Natalia S Rost; Anand Viswanathan; Jonathan Rosand; Steven M Greenberg; Eric E Smith
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

View more
  13 in total

1.  Delayed Seizures and Poor Functional Outcome After Intracranial Hemorrhage Is the Fate of Patients with a Poor Underlying Substrate, Say the Intensivists.

Authors:  Jong Woo Lee
Journal:  Epilepsy Curr       Date:  2017 Mar-Apr       Impact factor: 7.500

2.  Seizures and epilepsy after intracerebral hemorrhage: an update.

Authors:  Laurent Derex; Sylvain Rheims; Laure Peter-Derex
Journal:  J Neurol       Date:  2021-02-10       Impact factor: 4.849

3.  Re: Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality.

Authors:  Andrew M Naidech; Matthew B Maas; Eric M Liotta; James C Guth; Rebecca M Bauer; Rajeev K Garg; Stephan U Schuele; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

4.  Prophylactic Antiepileptic Drug Use and Outcome in the Ethnic/Racial Variations of Intracerebral Hemorrhage Study.

Authors:  Kevin N Sheth; Sharyl R Martini; Charles J Moomaw; Sebastian Koch; Mitchell S V Elkind; Gene Sung; Steven J Kittner; Michael Frankel; Jonathan Rosand; Carl D Langefeld; Mary E Comeau; Salina P Waddy; Jennifer Osborne; Daniel Woo
Journal:  Stroke       Date:  2015-10-15       Impact factor: 7.914

Review 5.  Antiseizure medications in critical care: an update.

Authors:  Baxter Allen; Paul M Vespa
Journal:  Curr Opin Crit Care       Date:  2019-04       Impact factor: 3.687

6.  Disparities in the Use of Seizure Medications After Intracerebral Hemorrhage.

Authors:  Andrew M Naidech; Paloma Toledo; Shyam Prabhakaran; Jane L Holl
Journal:  Stroke       Date:  2017-01-19       Impact factor: 7.914

7.  Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study.

Authors:  Andrew M Naidech; Jennifer Beaumont; Babak Jahromi; Shyam Prabhakaran; Abel Kho; Jane L Holl
Journal:  Neurology       Date:  2016-11-18       Impact factor: 9.910

Review 8.  Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Authors:  Thomas J Cusack; J Ricardo Carhuapoma; Wendy C Ziai
Journal:  Curr Treat Options Neurol       Date:  2018-02-03       Impact factor: 3.598

9.  Prophylactic Use of Antiepileptic Drugs in Patients with Spontaneous Intracerebral Hemorrhage.

Authors:  Ali Zandieh; Steven R Messé; Brett Cucchiara; Michael T Mullen; Scott E Kasner
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-06-08       Impact factor: 2.136

10.  Prescription patterns for routine EEG ordering in patients with intracranial hemorrhage admitted to a neurointensive care unit.

Authors:  Mehdi Ghasemi; Muhammad Umer Azeem; Susanne Muehlschlegel; Felicia Chu; Nils Henninger
Journal:  J Crit Care       Date:  2019-01-11       Impact factor: 3.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.